{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/graviton-bioscience-corporation-announces-publication-of-positive-ph1b-trial-results-for-gv101-tdi01-in-chronic-graft-versus-host-disease-in-signal-transduction-and-targeted-therapy-by-beijing-tide-pharmaceutical-302860706.html", "message": "News view counter 903273 successfully enlarged"}